TCM
AGIO icon

Teza Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Teza Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,081
Closed -$335K – 325
2021
Q2 		$335K Buy
+6,081
New +$340K 0.05% 412
2020
Q3 		– Sell
-12,974
Closed -$694K – 357
2020
Q2 		$694K Buy
+12,974
New +$601K 0.15% 201
2020
Q1 		– Sell
-20,025
Closed -$956K – 131
2019
Q4 		$956K Buy
+20,025
New +$757K 0.26% 105

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Teza Capital Management's AGIO Position: Q3 2021 in Review

Teza Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 6,081 shares — an estimated $335K sold.

Teza Capital Management first reported a position in AGIO in Q4 2019 and held it in 3 quarters. The position peaked at $956K in Q4 2019. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Teza Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Teza Capital Management sold 6,081 Agios Pharmaceuticals shares in Q3 2021, an estimated $335K.
  • Teza Capital Management first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Teza Capital Management's Agios Pharmaceuticals position peaked at $956K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Teza Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.